Most previous studies addressing the association of body size, weight chang
e and body fat distribution with the risk of breast cancer were conducted i
n Western societies with a high proportion of overweight people. It remains
unclear whether the dose-response relation observed in earlier studies can
be extended to women with "normal" weight based on prevailing Western stan
dards. To address this issue, we analyzed data from a population-based case
-control study of breast cancer recently completed among Chinese women in u
rban Shanghai. In-person interviews and anthropometric measurements were co
mpleted for 1,459 women newly diagnosed with breast cancer from 25 to 64 ye
ars of age and 1,556 controls frequency-matched to cases on age. Unconditio
nal logistic regression was employed to estimate adjusted odds ratios (ORs)
and 95% confidence intervals (CI) related to anthropometric variables and
self-reported body weight. Currently measured weight, body mass index [BMI:
weight (kg)/height(m)(2)] or height was each found to be positively relate
d to risk of postmenopausal breast cancer in a dose-response manner, with O
Rs (95% CI) being 2.0 (1.4-3.0), 2.0 (1.2-3.2) or 1.7 (1.2-2.5), respective
ly, for the highest category of weight, BMI or height compared to the lowes
t category of these variables. These variables were unrelated to premenopau
sal breast cancer risk. Reported weight at ages > 40 years and weight gain
after age 20 were more predictive for postmenopausal breast cancer than wei
ght at an earlier age. After adjustment for EM I, waist-to-hip ratio was re
lated to an increased risk of premenopausal [OR = 1.7 (1.3-2.3) for the hig
hest category compared to the lowest category] but not postmenopausal breas
t cancer. This study suggests that, even in a relatively thin Chinese popul
ation, weight gain and height are related to an increased risk of postmenop
ausal breast cancer, while central fat distribution was associated with pre
menopausal breast cancer. General weight control may be an effective measur
ement for breast cancer prevention. (C) 2001 Wiley-Liss, Inc.